pharma QA – Page 73 – Pharma.Tips

API impurity profile OOS after cleaning validation requalification: data integrity and chromatographic audit trail review steps

Investigating OOS Results for API Impurity Profiles Post-Cleaning Validation Requalification In the pharmaceutical manufacturing environment, the integrity and reliability of active pharmaceutical ingredient (API) impurity profiles are paramount. A recent…

Microbial Limits Failure after supplier change: GMP documentation for FDA/EMA/MHRA review

Understanding Microbial Limits Failure Following a Supplier Change in Pharmaceutical Manufacturing In the pharmaceutical manufacturing landscape, deviations related to microbial limits can pose significant compliance challenges, especially after a change…

Leakage Failure during line setup: method variability vs true product failure assessment

Assessing Leakage Failures During Line Setup: Evaluating Method Variability and True Product Performance In the complex environment of pharmaceutical manufacturing, maintaining consistent quality during production setups is essential. Leakage failures…

Spray Pattern Failure during line setup: method variability vs true product failure assessment

Assessing Spray Pattern Failure during Line Setup: An Investigation into Method Variability vs. Product Integrity A spray pattern failure in aerosol formulations during line setup can lead to significant quality…

API packaging moisture ingress issue after solvent change in last step: GMP investigation checklist and batch disposition evidence pack

GMP Investigation Checklist for API Packaging Moisture Ingress Post Solvent Change The pharmaceutical manufacturing landscape is fraught with complexities, particularly when it comes to ensuring the integrity of Active Pharmaceutical…

Leakage Complaint during bulk hold: investigation steps with CAPA evidence

Investigating Bulk Hold Leakage Complaints: Steps and CAPA Considerations Leakage during a bulk hold can trigger serious concerns in pharmaceutical manufacturing, leading to potential deviations, out-of-specification (OOS) reports, and regulatory…

Valve Malfunction at stability pull: packaging integrity and transport risk assessment

Assessing Valve Malfunction During Stability Testing: Packaging Integrity and Transport Risks In pharmaceutical manufacturing, the integrity of a product’s packaging is essential, particularly in stability testing where conditions are rigorously…

Drop Test Failure during EU/UK distribution qualification: method variability vs true product failure assessment

Assessing Drop Test Failures During EU/UK Distribution Qualification: Navigating Method Variability and True Product Failures In the pharmaceutical manufacturing landscape, ensuring product integrity and compliance during distribution qualification is critical.…

Crimp Diameter Variability after valve supplier change: method variability vs true product failure assessment

Assessing Crimp Diameter Variability Following a Change in Valve Supplier In the highly regulated landscape of pharmaceutical manufacturing, variability in critical quality attributes (CQAs) can lead to significant compliance challenges.…

API color / appearance change during commercial scale manufacture: control strategy updates for CPPs/CMAs and continued process verification

Addressing Color and Appearance Changes of APIs During Commercial Scale Manufacture Changes in the color and appearance of Active Pharmaceutical Ingredients (APIs) during commercial scale manufacture present serious challenges, impacting…

Sedimentation Oos in ear drop manufacturing: GMP documentation for FDA/EMA/MHRA review

Investigation of Sedimentation Issues in Ear Drop Manufacturing: A Guide for Compliance In the pharmaceutical industry, particularly in the production of ear drops, instances of out-of-specification (OOS) results related to…

Particle Size Distribution Oos at stability pull: packaging integrity and transport risk assessment

Addressing Deviations in Particle Size Distribution During Stability Evaluation In pharmaceutical manufacturing, adherence to quality standards is critical, particularly when it comes to particle size distribution (PSD) in aerosol formulations.…